We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+3.46%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$59.9B
AUM Growth
+$3.22B
(+5.7%)
Cap. Flow
+$2.93B
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
16.49%
Holding
2,255
New
142
Increased
870
Reduced
944
Closed
192
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$366M |
| 2 |
Paychex
PAYX
|
+$275M |
| 3 |
Deckers Outdoor
DECK
|
+$233M |
| 4 |
Texas Instruments
TXN
|
+$218M |
| 5 |
Merck
MRK
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$202M |
| 2 |
Flutter Entertainment
FLUT
|
+$170M |
| 3 |
DexCom
DXCM
|
+$147M |
| 4 |
Nutanix
NTNX
|
+$135M |
| 5 |
DoorDash
DASH
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.62% |
| 2 | Healthcare | 15.45% |
| 3 | Financials | 12.81% |
| 4 | Consumer Discretionary | 11.42% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1726
Castle Biosciences
CSTL
$1.03B
| $25.7K | ﹤0.01% |
+660
| New | +$21.3K |
2025 Q4
0 quarters
|
|
1727
DELISTED
Day One Biopharmaceuticals
DAWN
| $25.4K | ﹤0.01% |
2,730
-2,856
| -51% | -$23.9K |
2025 Q3
1 quarter
|
|
1728
Champion Homes
SKY
$4.34B
| $25.3K | ﹤0.01% |
299
-177
| -37% | -$13.9K |
2025 Q2
2 quarters
|
|
1729
Fastly Inc
FSLY
$3.99B
| $25K | ﹤0.01% |
2,460
+79
| +3% | +$779 |
2024 Q4
4 quarters
|
|
1730
Ziff Davis
ZD
$2B
| $25K | ﹤0.01% |
+711
| New | +$24.8K |
2025 Q4
0 quarters
|
|
1731
Diodes
DIOD
$3.93B
| $24.9K | ﹤0.01% |
505
-24,960
| -98% | -$1.26M |
2016 Q4
36 quarters
|
|
1732
Trinity Industries
TRN
$2.03B
| $24.9K | ﹤0.01% |
942
-461
| -33% | -$12.5K |
2013 Q2
50 quarters
|
|
1733
Vir Biotechnology
VIR
$1.77B
| $24.1K | ﹤0.01% |
4,005
-4,080
| -50% | -$24.3K |
2023 Q4
8 quarters
|
|
1734
Northeast Bank
NBN
$1.08B
| $24.1K | ﹤0.01% |
232
-136
| -37% | -$12.7K |
2017 Q4
32 quarters
|
|
1735
Xencor
XNCR
$1.78B
| $23.7K | ﹤0.01% |
1,548
-2,399
| -61% | -$35.8K |
2024 Q3
5 quarters
|
|
1736
Agilysys
AGYS
$3.2B
| $23.6K | ﹤0.01% |
+199
| New | +$24K |
2025 Q4
0 quarters
|
|
1737
EverCommerce
EVCM
$1.68B
| $23.5K | ﹤0.01% |
1,944
-1,132
| -37% | -$12K |
2025 Q2
2 quarters
|
|
1738
BGC Group
BGC
$5.41B
| $23.5K | ﹤0.01% |
2,633
-1,533
| -37% | -$13.8K |
2024 Q4
4 quarters
|
|
1739
Green Brick Partners
GRBK
$2.67B
| $23.4K | ﹤0.01% |
373
-218
| -37% | -$14.4K |
2020 Q2
22 quarters
|
|
1740
Campbell Soup
CPB
$5.92B
| $23.4K | ﹤0.01% |
838
-3
| -0.4% | -$90 |
2019 Q1
27 quarters
|
|
1741
International Seaways
INSW
$5.6B
| $23.3K | ﹤0.01% |
479
-279
| -37% | -$13.8K |
2022 Q3
13 quarters
|
|
1742
WisdomTree
WT
$3.27B
| $23.2K | ﹤0.01% |
1,903
-1,108
| -37% | -$13.4K |
2024 Q3
5 quarters
|
|
1743
Cytek Biosciences
CTKB
$703M
| $23.1K | ﹤0.01% |
4,579
+231
| +5% | +$1.07K |
2023 Q4
8 quarters
|
|
1744
Eagle Bancorp Montana
EBMT
$165M
| $23.1K | ﹤0.01% |
1,160
| – | – |
2025 Q2
2 quarters
|
|
1745
Digimarc Corp
DMRC
$151M
| $22.8K | ﹤0.01% |
3,478
+2,804
| +416% | +$23.8K |
2025 Q3
1 quarter
|
|
1746
Group 1 Automotive
GPI
$2.86B
| $22.8K | ﹤0.01% |
+58
| New | +$23.8K |
2025 Q4
0 quarters
|
|
1747
Brown-Forman Class B
BF.B
$13.1B
| $22.8K | ﹤0.01% |
875
-2
| -0.2% | -$56 |
2025 Q1
3 quarters
|
|
1748
Enerpac Tool Group
EPAC
$1.79B
| $22.6K | ﹤0.01% |
591
-33,086
| -98% | -$1.31M |
2023 Q1
11 quarters
|
|
1749
Fennec Pharmaceuticals
FENC
$363M
| $22.5K | ﹤0.01% |
2,916
| – | – |
2025 Q2
2 quarters
|
|
1750
Progyny
PGNY
$2.11B
| $22.3K | ﹤0.01% |
869
-506
| -37% | -$11.6K |
2019 Q4
24 quarters
|
|
Similar funds
Federated Hermes's Q4 2025 Portfolio in Review
As of Q4 2025, Federated Hermes held 2,255 positions worth $59.9B, up 5.7% from $56.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes deployed $2.93B of net new capital in Q4 2025, opening 142 new positions and adding to 870 existing holdings. Its largest new stake was Beta Technologies Inc: 1,075,413 shares worth $30.3M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $202M trimmed.
- Federated Hermes's largest Q4 2025 buy was Beta Technologies Inc: 1,075,413 shares worth $30.3M.
- Federated Hermes added most to Fiserv Inc in Q4 2025, an estimated $366M increase.
- Federated Hermes's biggest Q4 2025 reduction was Johnson & Johnson, cutting an estimated $202M.
- Federated Hermes fully exited Flutter Entertainment in Q4 2025, selling an estimated $170M.
- Federated Hermes's ten largest holdings make up 16% of its $59.9B portfolio in Q4 2025.
- Federated Hermes opened 142 new positions and closed 192 in Q4 2025.
- Federated Hermes's portfolio value rose 5.7% quarter-over-quarter to $59.9B.
Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.